Invention Grant
- Patent Title: Formulation comprising glycopyrrolate, method and apparatus
-
Application No.: US15509769Application Date: 2015-09-09
-
Publication No.: US10532041B2Publication Date: 2020-01-14
- Inventor: Fergus Manford
- Applicant: Vectura Limited
- Applicant Address: GB Wiltshire
- Assignee: Vectura Limited
- Current Assignee: Vectura Limited
- Current Assignee Address: GB Wiltshire
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Priority: EP14184164 20140909
- International Application: PCT/EP2015/070660 WO 20150909
- International Announcement: WO2016/038116 WO 20160317
- Main IPC: A61K31/40
- IPC: A61K31/40 ; A61K31/137 ; A61K31/4704 ; A61K31/573 ; A61K9/00 ; A61K9/50 ; A61K9/51 ; A61K31/138
Abstract:
A method is disclosed for making a pharmaceutical composition for pulmonary administration comprising co-jet milling glycopyrrolate and magnesium stearate, wherein the co-jet milled glycopyrrolate and magnesium stearate is then subjected to a conditioning step which includes exposure of the co-jet milled glycopyrrolate and magnesium stearate to humidity. A composition made by this method is also disclosed.
Public/Granted literature
- US20170258762A1 FORMULATION COMPRISING GLYCOPYRROLATE, METHOD AND APPARATUS Public/Granted day:2017-09-14
Information query
